eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

3/2008
vol. 33
 
Share:
Share:
more
 
 
abstract:

Clinical immunology
The effects of N-acetylcysteine and inhaled steroid on inflammatory and oxidative stress markers in chronic obstructive pulmonary disease (COPD)

Frans J. Van Overveld, Urszula A. Demkow, Dorota Górecka, Beata Białas-Chromiec, Anna M. Sadowska, Anna Goljan, Jacek Kołakowski, Wilfried A. de Backer, Jan Zielinski

(Centr Eur J Immunol 2008; 33 (3): 135-141)
Online publish date: 2008/05/05
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 

Introduction: Chronic obstructive pulmonary disease (COPD) is characterised by chronic airway inflammation with increased numbers of neutrophils in the airway lumen. Inhaled corticosteroids are widely used for the treatment of COPD despite of controversial statements concerning their efficiency. N-acetylcysteine is a mucolytic drug with antioxidant properties, counteracting the oxidant/antioxidant imbalance in COPD.

Objectives: The aim of the present study is to evaluate whether treatment of COPD patients with inhaled corticosteroid or N-acetylcysteine will change indices of inflammation and oxidative stress.

Material and Methods: Twenty COPD patients are treated for two times 10 weeks with fluticasone dipropionate (1000 µg/day) or N-acetylcysteine (600 mg/day) in a randomised crossover setting. Induced sputum and blood samples were collected every 10 weeks.

Results: Protective markers for oxidative stress, glutathione peroxidase (47.5±5.3 vs. 57.6±7.8 U/g Hb, P<0.05) and trolox-equivalent antioxidant capacity (1.41±0.05 vs. 1.50±0.06 mM, P<0.05) were increased by steroid treatment. N-acetylcysteine decreased significantly sputum eosinophil cationic protein (266±61 vs. 136±27 ng/ml, P<0.02), sputum interleukin-8 (403±65 vs. 326±62 ng/ml, P=0.05), and sputum tryptase, a serine protease (1.80±0.29 vs. 1.33±0.16 ng/ml, P<0.01).

Conclusions: These results suggest inhaled steroids have no action on inflammatory indices in the treatment of COPD, while N-acetylcysteine has some anti-inflammatory actions. Furthermore, steroids seem to have a positive influence on oxidant/antioxidant imbalance that is thought to be important in the pathogenesis of COPD.
keywords:

treatment, induced sputum, inflammatory markers, oxidative stress

FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe